Correspondence
Circular 001/2022: Reclassification of GHB and related substances
A change to the Misuse of Drugs Act 1971: reclassification of Gamma-Hydroxybutyric Acid, Gamma-Butyrolactone and 1,4-Butanediol from Class C to Class B.
Documents
Details
This circular draws attention to the contents of the below Statutory Instrument (SI), S.I. 2022/322 which will come into force at one minute past midnight on 13 April 2022:
- The Misuse of Drugs Act 1971 (Amendment) Order 2022 (S.I. 2022/322)
The Misuse of Drugs Act 1971 (Amendment) Order 2022 reclassifies GHB, GBL and 1,4-BD as Class B drugs under paragraph 1(a) of Part 2 of Schedule 2 to the Misuse of Drugs Act 1971 (“the 1971 Act”).
The SI is available at www.legislation.gov.uk, as follows:
- S.I. 2022/322 - The Misuse of Drugs Act 1971 (Amendment) Order 2022 (legislation.gov.uk)
Published 13 April 2022